Avalyn Pharma Inc recorded significant insider buying activity on May 1, 2026. Novo Holdings A/S, Jill Carroll, and SR One Capital Management, LLC collectively acquired over 1.3 million shares. These transactions represent the most recent recorded activity, occurring more than three months ago, with no subsequent trades reported since that date.